Meet the 2011 Rock Docs
Amanda Cashen, MD
Assistant Professor of Medicine, Division of Oncology, Section of Bone Marrow Transplantation, Washington University School of Medicine and Siteman Cancer Center
Dr. Amanda Cashen specializes in the treatment of Non-Hodgkin and Hodgkin lymphoma. She is interested in the use of novel agents for the treatment of relapsed disease and improving autologous stem cell collection in lymphoma patients with AMD3100. Along with the bone marrow and stem cell transplant team, Dr. Cashen celebrated the 5,000th transplant at Siteman in July 2011. Learn more about Dr. Cashen here and the BMT milestone here.
Paul Goodfellow, PhD
Professor of Surgery, of Genetics and of Obstetrics and Gynecology, Washington University School of Medicine and Siteman Cancer Center
Dr. Paul Goodfellow's research is focused on the discovery of genetic factors that contribute to the development of common human malignancies. He is particularly interested in uncovering the inherited factors that predispose to cancer development and how they interact with acquired genetic damage. Learn more about Dr. Goodfellow here.
Allison King, MD
Assistant Professor of Pediatrics and Occupational Therapy, Washington University School of Medicine and Siteman Cancer Center
Dr. Allison King is a pediatric hematologist and oncologist. She focuses her research on educational outcomes of two populations of children with chronic diseases: children with sickle cell disease and children with brain tumors. She is investigating variables related to academic achievement and self-sufficiency. Learn more about Dr. King here.
Rakesh Nagarajan, MD, PhD
Chair, Center for Biomedical Informatics; Assistant Professor, Pathology & Immunology; Washington University School of Medicine and Siteman Cancer Center
The goal of Dr. Nagarajan's biomedical research is to uncover perturbations in important pathways that lead to disease states so that therapeutic treatments may be designed. In the Nagarajan Lab, simultaneous monitoring of DNA, RNA, and protein is made possible by conducting clinical and biomedical informatics research, the development of software applications, and the utilization of algorithms to identify potential diagnostic markers and therapeutic targets. Learn more about Dr. Nagarajan here and the Nagarajan Lab here
Reid Townsend, MD, PhD
Associate Professor of Medicine, Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine and Siteman Cancer Center
Dr. Reid Townsend's primary research interest is the discovery and validation of biomarkers in tissues and biological fluids using proteomics and metabolomics. His laboratory has ongoing collaborative protein biomarker projects in cancer (pancreatic, breast, prostate and bladder) and Alzheimer's disease. Dr. Townsend is an important part of the newly announced Clinical Proteomic Tumor Analysis Consortium (CPTAC), supported by the National Cancer Institute (NCI). Along with Dr. Matthew Ellis, the hope is to accelerate the understanding of the molecular basis of cancer. Learn more about Dr. Townsend here and the CPTAC here.
